434 related articles for article (PubMed ID: 28463931)
21. Utility of quantitative apparent diffusion coefficient measurements and normalized apparent diffusion coefficient ratios in the diagnosis of clinically significant peripheral zone prostate cancer.
Nguyen TB; Ushinsky A; Yang A; Nguyentat M; Fardin S; Uchio E; Lall C; Lee T; Houshyar R
Br J Radiol; 2018 Jul; 91(1088):20180091. PubMed ID: 29869921
[TBL] [Abstract][Full Text] [Related]
22. Does the Prostate Imaging-Reporting and Data System (PI-RADS) version 2 improve accuracy in reporting anterior lesions on multiparametric magnetic resonance imaging (mpMRI)?
Hoffmann R; Logan C; O'Callaghan M; Gormly K; Chan K; Foreman D
Int Urol Nephrol; 2018 Jan; 50(1):13-19. PubMed ID: 29188489
[TBL] [Abstract][Full Text] [Related]
23. Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference.
Vargas HA; Hötker AM; Goldman DA; Moskowitz CS; Gondo T; Matsumoto K; Ehdaie B; Woo S; Fine SW; Reuter VE; Sala E; Hricak H
Eur Radiol; 2016 Jun; 26(6):1606-12. PubMed ID: 26396111
[TBL] [Abstract][Full Text] [Related]
24. Implementation of a 5-Minute Magnetic Resonance Imaging Screening Protocol for Prostate Cancer in Men With Elevated Prostate-Specific Antigen Before Biopsy.
Weiss J; Martirosian P; Notohamiprodjo M; Kaufmann S; Othman AE; Grosse U; Nikolaou K; Gatidis S
Invest Radiol; 2018 Mar; 53(3):186-190. PubMed ID: 29077588
[TBL] [Abstract][Full Text] [Related]
25. Same-day repeatability and Between-Sequence reproducibility of Mean ADC in PI-RADS lesions.
Zhang KS; Neelsen CJO; Wennmann M; Glemser PA; Hielscher T; Weru V; Görtz M; Schütz V; Stenzinger A; Hohenfellner M; Schlemmer HP; Bonekamp D
Eur J Radiol; 2023 Aug; 165():110898. PubMed ID: 37331287
[TBL] [Abstract][Full Text] [Related]
26. MRI features of the normal prostatic peripheral zone: the relationship between age and signal heterogeneity on T2WI, DWI, and DCE sequences.
Bura V; Caglic I; Snoj Z; Sushentsev N; Berghe AS; Priest AN; Barrett T
Eur Radiol; 2021 Jul; 31(7):4908-4917. PubMed ID: 33398421
[TBL] [Abstract][Full Text] [Related]
27. Prostate imaging reporting and data system version 2 (PI-RADS v2): a pictorial review.
Hassanzadeh E; Glazer DI; Dunne RM; Fennessy FM; Harisinghani MG; Tempany CM
Abdom Radiol (NY); 2017 Jan; 42(1):278-289. PubMed ID: 27522352
[TBL] [Abstract][Full Text] [Related]
28. Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume.
Mazaheri Y; Hricak H; Fine SW; Akin O; Shukla-Dave A; Ishill NM; Moskowitz CS; Grater JE; Reuter VE; Zakian KL; Touijer KA; Koutcher JA
Radiology; 2009 Aug; 252(2):449-57. PubMed ID: 19703883
[TBL] [Abstract][Full Text] [Related]
29. Targeted Biopsy Validation of Peripheral Zone Prostate Cancer Characterization With Magnetic Resonance Fingerprinting and Diffusion Mapping.
Panda A; OʼConnor G; Lo WC; Jiang Y; Margevicius S; Schluchter M; Ponsky LE; Gulani V
Invest Radiol; 2019 Aug; 54(8):485-493. PubMed ID: 30985480
[TBL] [Abstract][Full Text] [Related]
30. Multiparametric magnetic resonance imaging characteristics of normal, benign and malignant conditions in the prostate.
De Visschere PJ; Vral A; Perletti G; Pattyn E; Praet M; Magri V; Villeirs GM
Eur Radiol; 2017 May; 27(5):2095-2109. PubMed ID: 27491874
[TBL] [Abstract][Full Text] [Related]
31. T1 Mapping of the Prostate Using Single-Shot T1FLASH: A Clinical Feasibility Study to Optimize Prostate Cancer Assessment.
Al-Bourini O; Seif Amir Hosseini A; Giganti F; Balz J; Heitz LG; Voit D; Lotz J; Trojan L; Frahm J; Uhlig A; Uhlig J
Invest Radiol; 2023 Jun; 58(6):380-387. PubMed ID: 36729865
[TBL] [Abstract][Full Text] [Related]
32. The impact of multiparametric MRI features to identify the presence of prevalent cribriform pattern in the peripheral zone tumors.
Gaudiano C; Bianchi L; De Cinque A; Corcioni B; Giunchi F; Schiavina R; Fiorentino M; Brunocilla E; Golfieri R
Radiol Med; 2022 Feb; 127(2):174-182. PubMed ID: 34850354
[TBL] [Abstract][Full Text] [Related]
33. Multiparametric Magnetic Resonance Imaging for Discriminating Low-Grade From High-Grade Prostate Cancer.
Vos EK; Kobus T; Litjens GJ; Hambrock T; Hulsbergen-van de Kaa CA; Barentsz JO; Maas MC; Scheenen TW
Invest Radiol; 2015 Aug; 50(8):490-7. PubMed ID: 25867656
[TBL] [Abstract][Full Text] [Related]
34. Comparison of T2-Weighted Imaging, DWI, and Dynamic Contrast-Enhanced MRI for Calculation of Prostate Cancer Index Lesion Volume: Correlation With Whole-Mount Pathology.
Sun C; Chatterjee A; Yousuf A; Antic T; Eggener S; Karczmar GS; Oto A
AJR Am J Roentgenol; 2019 Feb; 212(2):351-356. PubMed ID: 30540213
[TBL] [Abstract][Full Text] [Related]
35. Test-retest repeatability of ADC in prostate using the multi b-Value VERDICT acquisition.
Rogers HJ; Singh S; Barnes A; Obuchowski NA; Margolis DJ; Malyarenko DI; Chenevert TL; Shukla-Dave A; Boss MA; Punwani S
Eur J Radiol; 2023 May; 162():110782. PubMed ID: 37004362
[TBL] [Abstract][Full Text] [Related]
36. Apparent Diffusion Coefficient Values of the Benign Central Zone of the Prostate: Comparison With Low- and High-Grade Prostate Cancer.
Gupta RT; Kauffman CR; Garcia-Reyes K; Palmeri ML; Madden JF; Polascik TJ; Rosenkrantz AB
AJR Am J Roentgenol; 2015 Aug; 205(2):331-6. PubMed ID: 26204283
[TBL] [Abstract][Full Text] [Related]
37. Quantified analysis of histological components and architectural patterns of gleason grades in apparent diffusion coefficient restricted areas upon diffusion weighted MRI for peripheral or transition zone cancer locations.
Helfrich O; Puech P; Betrouni N; Pinçon C; Ouzzane A; Rizk J; Marcq G; Randazzo M; Durand M; Lakroum S; Leroy X; Villers A
J Magn Reson Imaging; 2017 Dec; 46(6):1786-1796. PubMed ID: 28383776
[TBL] [Abstract][Full Text] [Related]
38. Comparison of Prostate Imaging Reporting and Data System versions 1 and 2 for the Detection of Peripheral Zone Gleason Score 3 + 4 = 7 Cancers.
Krishna S; McInnes M; Lim C; Lim R; Hakim SW; Flood TA; Schieda N
AJR Am J Roentgenol; 2017 Dec; 209(6):W365-W373. PubMed ID: 28981356
[TBL] [Abstract][Full Text] [Related]
39. A self-tuned graph-based framework for localization and grading prostate cancer lesions: An initial evaluation based on multiparametric magnetic resonance imaging.
Chen W; Lin M; Gibson E; Bastian-Jordan M; Cool DW; Kassam Z; Liang H; Feng G; Ward AD; Chiu B
Comput Biol Med; 2018 May; 96():252-265. PubMed ID: 29653354
[TBL] [Abstract][Full Text] [Related]
40. Stratification of the aggressiveness of prostate cancer using pre-biopsy multiparametric MRI (mpMRI).
Dwivedi DK; Kumar R; Bora GS; Thulkar S; Sharma S; Gupta SD; Jagannathan NR
NMR Biomed; 2016 Mar; 29(3):232-8. PubMed ID: 26730884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
